People with chronic lung disease often struggle to exercise or feel their heart racing. A new analysis of data from 171 adults with COPD and 105 healthy controls explains why. The study found that the nerves controlling the heart and blood vessels fire much more often in people with COPD than in healthy people. This extra nerve firing is called sympathetic excitation. It acts like a constant stress signal to the body. The data showed this nerve activity was markedly higher in the COPD group. Specifically, the frequency of these nerve bursts was 18.5 units higher on average. The rate of these bursts per heartbeat was also 21.3 units higher. These differences were clear and consistent across the group. The study also looked at resting heart rate. It found that heart rate was elevated by about 10.7 beats per minute in the COPD group. Blood pressure did not differ significantly between the two groups. The researchers tested whether treatments like noninvasive ventilation or inhaled beta-agonists changed this nerve activity. The pooled results showed no significant changes with these treatments. This does not mean the treatments are useless, but it suggests they do not directly calm this specific nerve signal. The study highlights the importance of developing therapies that reduce this sympathetic nerve activity. This chronic excitation likely contributes to the heart problems and exercise intolerance seen in COPD. Understanding this nerve signal helps doctors see the full picture of the disease beyond just lung function.
COPD patients have much higher nerve activity than healthy adults
Photo by National Cancer Institute / Unsplash
What this means for you:
COPD patients have significantly higher sympathetic nerve activity than healthy adults. More on Chronic Obstructive Pulmonary Disease
1 in 7 COPD patients decline or discontinue long-term PAP therapy, meta-analysis finds 1 in 7 COPD patients decline or stop breathing therapy
· Jun 4, 2026
Diabetes mellitus linked to higher SSI risk after hernia repair, other factors not significant Large study shows diabetes may raise infection risk during hernia repair surgery for patients
Frontiers · Jun 3, 2026
FAM13A variants influence tissue destruction in COPD and fibrotic remodeling in pulmonary fibrosis New research links FAM13A gene to lung disease tissue changes
Frontiers · Jun 2, 2026
Combination voriconazole and micafungin improved a boy with CGD and invasive Aspergillus lentulus infection Combination antifungals helped a boy with rare lung infection before transplant
Frontiers · Jun 2, 2026